Cause and Importance of the Age-dependent Sarcopenia (SARCOPENIA)
Status
Conditions
Details and patient eligibility
About
The goal of this cross-sectional study is to evaluate the difference in cytokine profiling approach and mitochondrial function between geriatric sarcopenic patients (group 1) and geriatric non-sarcopenic patients (group 2) and healthy (group 3) geriatric participants.
Full description
Study participants (group 1&2) are assessed during the hospital stay and age-matched controls (group 3) will be recruited through Flyers.
The investigators aim to isolate and cryopreserve peripheral blood mononuclear cells (PBMCs) from whole blood to perform functional assays on mitochondrial respiratory capacity and ROS. Furthermore, the investigators will investigate the association between biomarkers and frailty, quality of life, functional performance, fatigue and risk of depression.
The investigators hypothesize that this profiling approach will allow the evaluation of the progression of age-dependent sarcopenia and uncover novel therapeutic targets.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age between 60 and 85 years
- Informed written consent
- Normal cognitive status according to Mini-Mental State Examination (MMSE ≥ 24 points)
- Life expectancy of > 3 months according to treating doctor
- without implanted Defibrillation
- without acute Sepsis
- without neurodegenerative diseases, especially amyotrophic lateral sclerosis (ALS) and Huntington
Exclusion criteria
- Age < 60 years or > 85 years
- Lack of informed written consent
- Low cognitive status according to Mini-Mental State Examination (MMSE < 24 points)
- Life expectancy of < 3 months according to treating doctor
- Implanted Defibrillation
- Acute Sepsis
- neurodegenerative diseases, especially amyotrophic lateral sclerosis (ALS) and Huntington
Trial design
150 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal